TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Alligator Bioscience AB ( (SE:ATORX) ) has provided an update.
Alligator Bioscience AB held an extraordinary general meeting on November 25, 2025, where several key resolutions were adopted. The company decided to amend its Articles of Association to adjust the limits for share capital and the number of shares, and to decrease its share capital to cover losses. Additionally, the meeting approved a rights issue of units, which is expected to raise approximately SEK 123 million before costs, and authorized the board to issue shares and warrants to guarantors and Fenja Capital II A/S as part of a loan restructuring. These measures aim to strengthen the company’s financial position and support its ongoing development efforts.
More about Alligator Bioscience AB
Alligator Bioscience AB is a biotechnology company based in Lund, Sweden, focused on developing innovative antibody-based therapies for cancer treatment.
Average Trading Volume: 1,128,250
Technical Sentiment Signal: Sell
Current Market Cap: SEK37.3M
For detailed information about ATORX stock, go to TipRanks’ Stock Analysis page.